Physician profile
Rishin Handa
NPI 1497105415
$46,024.66
in general payments reported to CMS, 2019-2025
14 companies · $16K in 2025
The $16K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $128 · 2021: $36.84 · 2022: $5,854 · 2023: $10K · 2024: $14K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $21K · Food and Beverage: $11K · Grant: $6,788 · Education: $972.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $20,911.27 |
| Food and Beverage | $11,333.80 |
| Grant | $6,788.38 |
| Education | $971.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $24,839.51 | 2021-2025 | Ensite Precision, Ensite, Aveir |
| Medtronic, INC. | $6,382.54 | 2022-2025 | Micra, Evera Mri Xt Dr Surescan, Selectsecure |
| Biotronik INC. | $5,367.75 | 2022-2025 | Acticor 7 Vr-T Dx, Pamira, Amvia Edge |
| Boston Scientific Corporation | $4,376.83 | 2022-2025 | Watchman Access System, Watchman Flx, General - Therapies |
| Biosense Webster, INC. | $2,492.69 | 2024-2025 | Carto 3, Qdot Micro |
| Medical Device Business Services, INC. | $1,672.80 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $200.14 | 2022-2023 | Camzyos, Eliquis |
| Pfizer INC. | $196.89 | 2021-2024 | |
| Irhythm Technologies, INC. | $145.89 | 2024 | Zio Xt Patch, Zio Monitor |
| Astrazeneca Pharmaceuticals Lp | $133.49 | 2020-2022 | |
| Terumo Medical Corporation | $97.95 | 2023 | Angio-Seal, Heartrail, Tr Band |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $91.38 | 2025 | Lifevest |
| Cardiovascular Systems INC. | $13.70 | 2022 | |
| Lantheus Medical Imaging, INC. | $13.10 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rishin Handa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.